Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (321-330 of 8,370) with videos related to

Pageof 837
Sort By:
Drugs|October 19, 2020
Correction to: Oliceridine: First ApprovalAnthony Markham
Drugs|October 19, 2020
Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta-Analysis with a 6-Month Time HorizonC Beaudart, L Lengelé, V Leclercq, et al.
Drugs|September 3, 2020
Correction to: Risankizumab: A Review in Moderate to Severe Plaque PsoriasisHannah A Blair
Drugs|September 4, 2020
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19"John G Rizk, Kamyar Kalantar-Zadeh, Mandeep R Mehra, et al.
Drugs|September 4, 2020
Comment on: "Pharmaco-Immunomodulatory Therapy in COVID-19"Dimitrios A Vrachatis, Sotiria G Giotaki, George Giannopoulos, et al.
Drugs|January 1, 1988
Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover studyJ L Anderton, B D Vallance, N N Stanley, et al.
Drugs|September 7, 2020
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast CancerSara E Nunnery, Ingrid A Mayer
Drugs|September 8, 2020
Triheptanoin: First ApprovalMatt Shirley
Drugs|September 9, 2020
Correction to: Fostemsavir: First ApprovalAnthony Markham
Drugs|September 15, 2020
Apalutamide: A Review in Metastatic Castration-Sensitive Prostate CancerSheridan M Hoy
Pageof 837

Showing results (321-330 of 8,370) with videos related to

Sort By:
Pageof 837
Drugs|October 19, 2020
Correction to: Oliceridine: First ApprovalAnthony Markham
Drugs|October 19, 2020
Symptomatic Efficacy of Pharmacological Treatments for Knee Osteoarthritis: A Systematic Review and a Network Meta-Analysis with a 6-Month Time HorizonC Beaudart, L Lengelé, V Leclercq, et al.
Drugs|September 3, 2020
Correction to: Risankizumab: A Review in Moderate to Severe Plaque PsoriasisHannah A Blair
Drugs|September 4, 2020
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19"John G Rizk, Kamyar Kalantar-Zadeh, Mandeep R Mehra, et al.
Drugs|September 4, 2020
Comment on: "Pharmaco-Immunomodulatory Therapy in COVID-19"Dimitrios A Vrachatis, Sotiria G Giotaki, George Giannopoulos, et al.
Drugs|January 1, 1988
Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover studyJ L Anderton, B D Vallance, N N Stanley, et al.
Drugs|September 7, 2020
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast CancerSara E Nunnery, Ingrid A Mayer
Drugs|September 8, 2020
Triheptanoin: First ApprovalMatt Shirley
Drugs|September 9, 2020
Correction to: Fostemsavir: First ApprovalAnthony Markham
Drugs|September 15, 2020
Apalutamide: A Review in Metastatic Castration-Sensitive Prostate CancerSheridan M Hoy
Pageof 837